Unique Access Medical (UAM) is pleased to announce our exciting new partnership with one of Asia’s leading providers of progressive medical care in the area of neuroscience, IBS Hospitals in New Delhi, India.
The “Institute of Brain and Spine,” as IBS is known, specializes in advanced neurology, neurosurgery, spine surgery, and joint replacement surgery, making them an ideal partner in our quest to deliver cutting-edge spinal cord treatments like Epidural Stimulation on a global scale.
UAM’s primary purpose is to shift the paradigm of spinal cord injury care, and deliver better outcomes to as many patients as possible. So expanding the availability of our innovative treatments to thousands of paraplegics and quadriplegics in India and other South Asian countries is a huge step forward.
The collaboration with IBS Hospitals — the first of what we hope will be many such partnerships aimed at widening our network of Epidural Stimulation centres — will be made official this December, 2018. It comes after months of due diligence, including multiple visits by UAM’s team of experts to the world-class IBS facilities in New Delhi.
While our state-of-the-art facility in Bangkok, Thailand, will continue to be the flagship treatment centre, UAM’s collaboration with IBS Hospitals provides spinal cord injury sufferers from around the world with another destination for advanced procedures, and effectively doubles the number of surgeons, scientists, and rehabilitation specialists devoted to improving their lives. To learn more about our partners and our next-generation spinal cord treatments, contact Unique Access Medical.